|
HMGN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.880000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.379200E-01 |
| Normal-vs-Stage2 |
4.627600E-02 |
| Normal-vs-Stage3 |
2.950200E-01 |
| Normal-vs-Stage4 |
5.068200E-01 |
| Stage1-vs-Stage2 |
1.960910E-03 |
| Stage1-vs-Stage3 |
1.723750E-02 |
| Stage1-vs-Stage4 |
1.192970E-01 |
| Stage2-vs-Stage3 |
2.118800E-01 |
| Stage2-vs-Stage4 |
1.701840E-01 |
| Stage3-vs-Stage4 |
7.897000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.581400E-01 |
| Normal-vs-AfricanAmerican |
7.885400E-01 |
| Normal-vs-Asian |
4.957700E-02 |
| Caucasian-vs-AfricanAmerican |
8.308200E-01 |
| Caucasian-vs-Asian |
2.516400E-02 |
| AfricanAmerican-vs-Asian |
2.239600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.903400E-01 |
| Normal-vs-Female |
9.883800E-01 |
| Male-vs-Female |
9.999200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.305400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.649800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.696000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.130800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.474000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.936600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.549410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.786400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.206800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.486400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.640260E-02 |
| Classical-VS-Follicular |
2.020000E-02 |
| Classical-VS-Other |
8.133000E-01 |
| Classical-VS-Normal |
2.407000E-01 |
| Tall-VS-Follicular |
8.864400E-01 |
| Tall-VS-Other |
3.850400E-01 |
| Tall-VS-Normal |
1.902430E-01 |
| Follicular-VS-Other |
5.711000E-01 |
| Follicular-VS-Normal |
2.481400E-01 |
| Other-VS-Normal |
8.085200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.726000E-01 |
| Normal-vs-N1 |
8.369200E-01 |
| N0-vs-N1 |
2.769400E-01 |
|
|
